Description

Disodium 4-[[[[2-[[[[3-(Methyloxy)Phenyl]Methyl]Amino]Carbonyl]-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidin-5-Yl]Methyl]Oxy]Methyl]Benzoate is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound matters as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the development of new chemical entities and specialty fine chemicals.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, especially those targeting specific enzyme pathways.
• API Development: Serves as a core scaffold for the research and development of new Active Pharmaceutical Ingredients with potential therapeutic applications.
• Biochemical Research: Used in life science research as a tool compound for studying biological mechanisms and structure-activity relationships (SAR).
• Fine Chemical Synthesis: Employed in custom synthesis and contract manufacturing for producing high-value, complex organic molecules.

Basic Information

Product Name	Disodium 4-[[[[2-[[[[3-(Methyloxy)Phenyl]Methyl]Amino]Carbonyl]-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidin-5-Yl]Methyl]Oxy]Methyl]Benzoate
CAS No.	869298-22-6
Molecular Formula	C25H22N3Na2O7S
Molecular Weight	545.50 g/mol
Synonyms	Disodium 4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoate; Benzoic acid, 4-[[[[2-[[[[3-(methoxyphenyl)methyl]amino]carbonyl]-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-5-yl]methyl]oxy]methyl]-, disodium salt; Thieno[2,3-d]pyrimidine-5-carboxamide derivative disodium salt; 869298-22-6; Advanced Pharmaceutical Intermediate B-869298
EINECS	Contact for details

Quality Control

Our Disodium 4-[[[[2-[[[[3-(Methyloxy)Phenyl]Methyl]Amino]Carbonyl]-4-Oxo-3,4-Dihydrothieno[2,3-D]Pyrimidin-5-Yl]Methyl]Oxy]Methyl]Benzoate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical R&D and cGMP starting material applications. A comprehensive Certificate of Analysis (COA) detailing purity, related substances, residual solvents, and other critical parameters is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 5.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.